Learn · Your thyroid, explained
Thyroid nodules found on scan: what to expect
Finding out you have a thyroid nodule can feel like a sudden jolt, especially if the radiologist's report uses words like "mass" or "lesion." The good news is straightforward: thyroid nodules are remarkably common, and the vast majority are benign. Your doctor's job now is to characterize what's there and decide if it needs monitoring, testing, or nothing at all.
This article walks you through what an ultrasound conversation typically covers, how doctors think about nodule risk, and why calm, systematic follow-up is the standard approach.
How common are thyroid nodules?
Thyroid nodules are found in roughly 16–67% of ultrasounds, depending on how carefully the sonographer looks and the resolution of the machine. In autopsy studies, they're even more common. The key insight: finding a nodule does not mean something is wrong with you or that your thyroid is failing. Most nodules are small, stable, and never cause problems.
The reason for this enormous range in detection rates is simple—better imaging finds more nodules, but finding more doesn't mean more people are sick. A nodule is an anatomical observation, not a diagnosis of disease.
Most thyroid nodules never grow, never cause symptoms, and never need treatment.
What's the difference between nodules and thyroid disease?
A nodule is a discrete lump of thyroid tissue. Thyroid disease—like hypothyroidism or Hashimoto's—refers to how well the gland produces or regulates hormones, measured by blood tests like TSH. You can have a nodule with normal hormone levels, or hormone problems with or without a nodule. They're separate questions.
Your doctor will likely order both an ultrasound (to look at the nodule's features) and blood tests (to assess thyroid function). Neither one predicts the other reliably. A worrisome-looking nodule on imaging doesn't mean your hormones are abnormal, and normal hormone levels don't rule out a nodule that needs monitoring.
What does the ultrasound report actually describe?
The radiologist notes the nodule's size, shape, echogenicity (how it appears on the sound wave), borders, and whether there are suspicious features like microcalcifications or abnormal lymph nodes nearby. These features are used to assign a risk category, often using a system called TI-RADS (Thyroid Imaging Reporting and Data System).
TI-RADS scores range from 1 (benign) to 5 (highly suspicious for cancer). Most nodules score 1–2. The score guides whether follow-up imaging is needed—some nodules are followed with ultrasound every 6 or 12 months, others every few years, and many need no follow-up at all. A score alone doesn't determine your next step; your doctor integrates the score with your age, sex, symptoms, and any family history of thyroid cancer.
- Size (small nodules are very unlikely to be cancer)
- Shape and borders (smooth vs. irregular)
- Internal echogenicity (solid, cystic, or mixed)
- Presence of microcalcifications or suspicious lymph nodes
- Growth on prior imaging (if available)
When might a nodule need a biopsy?
A biopsy (usually fine-needle aspiration, or FNA) is typically considered when a nodule is larger than about 1 cm and has imaging features that suggest increased risk of malignancy, or when a smaller nodule shows growth on follow-up ultrasound. The biopsy result guides whether surgery, close monitoring, or nothing is recommended.
Most biopsies come back benign or non-diagnostic (meaning the sample didn't contain enough cells to be certain). If a result is uncertain, your doctor may repeat the biopsy, do additional imaging, or simply follow the nodule with ultrasound over time. Very few nodules are cancer, and even when cancer is found, thyroid cancer is often slow-growing and highly treatable.
Biopsies are used selectively, not routinely, and most results are reassuring.
What happens if the nodule is benign?
If imaging features are clearly benign and the nodule is small, many doctors recommend no follow-up imaging at all. If the nodule is larger or has intermediate features, follow-up ultrasound in 6 months to 2 years is standard, depending on the TI-RADS score and your clinical context. Growth over years is common and usually doesn't change management.
Your thyroid hormone levels are assessed separately via blood tests. A benign nodule doesn't require hormone replacement or any medication. If your TSH is normal, thyroid function is not the issue. If your TSH is abnormal, that's managed independently of the nodule—discuss what does TSH actually measure and the full thyroid panel with your doctor to understand your specific results.
What should you ask your doctor?
At your follow-up visit, clarify the TI-RADS score or risk category your nodule was assigned, the size, and whether growth has occurred since prior imaging (if any). Ask what the recommended follow-up plan is and why—do you need ultrasound in 6 months, a year, or no follow-up? If a biopsy is recommended, ask why the radiologist thinks it's warranted and what the next step would be if the result is benign.
Write down the nodule size and date of the ultrasound so you have a baseline for future reference. If you're referred to an endocrinologist or surgeon, bring your imaging report and any prior ultrasounds—that information guides the conversation about your specific risk profile.
- What is the TI-RADS score or risk category?
- What is the nodule's size?
- Is there a prior ultrasound to compare for growth?
- What is the recommended follow-up plan and timeline?
- Do I need a biopsy, and if so, why?
This article is educational content from The Reset Series, produced under our editorial standards. It is not medical advice, it does not diagnose any condition, and it never recommends supplements or medication changes — laboratory results can only be interpreted by a clinician who knows your history.